1010396-29-8 Usage
Description
S-23, also known as the orally bioavailable nonsteroidal Selective Androgen Receptor Modulator (SARM), is a unique and powerful compound that has gained popularity among athletes worldwide. It is highly effective in increasing lean muscle mass and bone density, making it a safer alternative to anabolic steroids. With its ability to burn stubborn fat, S-23 is considered an excellent form of S-4 (Andarine) and is one of the best performance-enhancing drugs for solidifying muscles and achieving a more refined appearance.
Uses
Used in Fitness and Sports Industry:
S-23 is used as a performance-enhancing drug for increasing lean muscle mass and bone density, providing athletes with a safer and more effective alternative to anabolic steroids.
Used in Weight Loss Industry:
S-23 is used as a fat-burning agent for losing stubborn fat, helping individuals achieve a more toned and refined appearance.
Used in Anti-Aging Industry:
S-23 is used as an anti-aging supplement to improve muscle and bone health, promoting a more youthful and energetic appearance.
benefits
Increments both skeletal and bulkAdvances durable bulk and perseverance gainsPerfect for muscle solidifyingTotally sets off catabolism in a calorie shortageBuilds bone quality and decreases fat massImproves drive in peopleEncourages clients to hold increases long after a cycleNo swelling or liquid maintenanceStep by step instructions to Use S-23
Biological Activity
S-23 is a selective androgen receptor modulator (SARM). It binds to the AR (Ki = 1.7 nM) and induces AR-mediated transcriptional activation in CV-1 cells expressing the human receptor when used at a concentration of 10 nM. S-23 increases prostate, seminal vesicle, and levator ani muscle weights in castrated rats. It decreases testicular sperm concentration without reducing mounting behavior or the number of intromissions in intact rats when administered in combination with estradiol benzoate (Item No. 10006487). S-23 (3 mg/kg) also increases preference for sexually active intact males when administered to ovariectomized female rats.
Clinical Use
S-23 is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc as a potential male hormonal contraceptive. It binds to the androgen receptor more strongly than older drugs such as andarine with a Ki of 1.7 nM, and in animal studies it showed both a good ratio of anabolic to androgenic effects, and dose-dependent suppression of spermatogenesis with spontaneous recovery after cessation of treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1010396-29-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,0,3,9 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1010396-29:
(9*1)+(8*0)+(7*1)+(6*0)+(5*3)+(4*9)+(3*6)+(2*2)+(1*9)=98
98 % 10 = 8
So 1010396-29-8 is a valid CAS Registry Number.
1010396-29-8Relevant articles and documents
METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
-
Paragraph 0450-0451, (2016/05/10)
The present invention is directed to methods of treating, preventing, suppressing and/or inhibiting urological disorders such as urinary incontinence including stress urinary incontinence and pelvic-floor disorders by administering a SARM compound of the invention.
Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators
Bohl, Casey E.,Wu, Zengru,Chen, Jiyun,Mohler, Michael L.,Yang, Jun,Hwang, Dong Jin,Mustafa, Suni,Miller, Duane D.,Bell, Charles E.,Dalton, James T.
supporting information; experimental part, p. 5567 - 5570 (2009/06/30)
Selective androgen receptor modulators (SARMs) are essentially prostate sparing androgens, which provide therapeutic potential in osteoporosis, male hormone replacement, and muscle wasting. Herein we report crystal structures of the androgen receptor (AR) ligand-binding domain (LBD) complexed to a series of potent synthetic nonsteroidal SARMs with a substituted pendant arene referred to as the B-ring. We found that hydrophilic B-ring para-substituted analogs exhibit an additional region of hydrogen bonding not seen with steroidal compounds and that multiple halogen substitutions affect the B-ring conformation and aromatic interactions with Trp741. This information elucidates interactions important for high AR binding affinity and provides new insight for structure-based drug design.
